Oxytocin 10mg*10vials

▎Oxytocin Structure

▎Oxytocin Research

What is the research background of Oxytocin?

Early Observations of Reproduction-related Phenomena: 

As early as ancient times, people noticed that the uterus of women would contract regularly during childbirth, and this contraction was crucial for the delivery of the fetus. However, at that time, it was unclear what substance mediated this contraction. With the development of medicine, people gradually began to explore the physiological mechanisms related to childbirth and reproduction, laying the foundation for the later discovery of oxytocin.

Animal Experiments and Preliminary Discovery: 

In 1906, the British physiologist Henry Hallett Dale, when studying the reproductive physiology of animals, found that pituitary extracts could cause the contraction of uterine smooth muscles. This discovery initiated an in-depth study of the relationship between the pituitary gland and reproductive physiology. Subsequently, through a large number of experiments, scientists further determined that there was a certain substance in the pituitary gland that had the effect of promoting uterine contraction and milk ejection from the mammary glands.

Isolation and Naming: 

In 1953, Vincent du Vigneaud successfully isolated oxytocin from the posterior pituitary lobe of cows and determined its chemical structure, which is a polypeptide composed of 9 amino acids. He was awarded the Nobel Prize in Chemistry in 1955 for his outstanding contributions in the field of biochemistry, especially his achievements in the research of peptide hormones. Since then, oxytocin has been recognized as a definite chemical substance, and its source has also been clearly identified as the posterior pituitary lobe.

Research at the Gene Level: 

With the development of molecular biology techniques, scientists have further studied the source mechanism of oxytocin in depth. It was found that oxytocin is synthesized by neurons in the paraventricular nucleus and supraoptic nucleus of the hypothalamus. These neurons synthesize the oxytocin precursor through the processes of gene transcription and translation, and then after a series of processing and modification, the bioactive oxytocin is finally formed. After synthesis, oxytocin is transported along the axons of neurons to the neurohypophysis (posterior pituitary lobe) for storage. When the body needs it, it will be released into the bloodstream to exert its physiological effects.

What is the mechanism of action of Oxytocin?

1. The Mechanism of Action on Childbirth and Uterine Contraction

Receptor Regulation: 

The oxytocin receptor (OTR) belongs to the rhodopsin-type (Class 1) superfamily of G protein-coupled receptors^[1]. During pregnancy and childbirth, changes in receptor expression, desensitization, and local oxytocin concentration will regulate its function. For example, during childbirth, the increase in endogenous oxytocin levels will increase the expression of oxytocin receptors, thereby enhancing the sensitivity of the myometrium to oxytocin.

Calcium Ion Regulation: 

After receptor activation, a series of signal events will be triggered to stimulate uterine contraction, mainly by increasing the intracellular calcium ion (Ca⊃2;⁺) concentration^[1]. This includes inositol-tris-phosphate-mediated calcium store release, store-operated Ca⊃2;⁺ entry, and voltage-operated Ca⊃2;⁺ entry. These changes in calcium ions will cause the contraction of myometrial cells, thus facilitating the delivery of the fetus.

2. The Mechanism of Action on Social Behavior

Neural Regulation: 

Oxytocin is mainly produced by the hypothalamus and plays an important role in the social behavior of mammals, including parental behavior, the formation of social relationships, and the management of experiences in response to stress^[2]. It responds to stressors and plays a role in the regulation of the central and autonomic nervous systems, including effects on immune and cardiovascular functions. Currently, it is believed that oxytocin may affect social behavior by regulating neural circuits in the brain. For example, in the process of forming social relationships, oxytocin may promote the activity of neurons in specific brain regions, enhancing trust and a sense of closeness to others.

3. The Mechanism of Action in Analgesia

Regulation of Physiological Processes: 

Oxytocin can relieve tension and pain without other adverse effects^[3]. Current research shows that oxytocin may exert its analgesic effect by regulating the pain conduction pathway in the nervous system. For example, it may inhibit the transmission of pain signals or regulate the activity of regions in the brain related to pain perception and emotional responses.

4. The Mechanism of Action in Migraine

Receptor Expression and Function: 

In the study of migraine, it was found that the oxytocin receptor (OTR) is widely expressed in the trigeminovascular system of rats ^[4]. Especially in the trigeminal ganglion, OTR is mainly expressed in Aδ sensory neurons and fibers, and a small number of OTRs in C fiber sensory neurons co-localize with calcitonin gene-related peptide (CGRP). OTR is also expressed in the caudal nucleus of the trigeminal nerve. However, oxytocin has no effect on the potassium ion-induced release of CGRP from isolated trigeminal ganglia or trigeminal ganglion afferent fibers in the dura mater.

Vascular Action: 

Peripheral cranial arteries contract in response to oxytocin in vitro, and this response can be blocked by the OTR antagonist L368899. In addition, oxytocin immunoreactivity was found in satellite glial cells of the trigeminal ganglion, but oxytocin mRNA was not detected in the trigeminal ganglion. Therefore, circulating oxytocin is most likely to affect pain conduction by acting on OTRs in the trigeminal ganglion, which may help explain the influence of hormones in migraines and provide a new target for treatment^[4].

Source:PubMed^[3]

What are the applications of Oxytocin?

1. Applications in Obstetrics

Promoting Childbirth: 

In obstetrics, oxytocin can be used to strengthen uterine contractions and promote childbirth. For some parturients with uterine atony, exogenous oxytocin can help achieve a successful vaginal delivery. For example, in some parturients with specific conditions, such as the mother having preeclampsia, gestational diabetes mellitus, premature rupture of membranes, the need to stimulate labor when the uterus is inactive, and inevitable or incomplete miscarriage in the second trimester, oxytocin is approved for prenatal use by the U.S. Food and Drug Administration (FDA)^[5].

2. Treatment of Chronic Pain

For adults with chronic neuropathic, pelvic, and musculoskeletal pain, intranasal administration of oxytocin may have a certain effect on improving pain and function. In a placebo-controlled, triple-blind, sequential, within-subject crossover trial, patients self-administered three different doses of oxytocin nasal spray (24IU, 48IU, and placebo) twice a day for 2 weeks. The primary outcomes included pain and pain-related interference, and the secondary outcomes included emotional function, sleep disorders, and the overall impression of change. The intention-to-treat analysis will evaluate whether pain and physical function will be improved after treatment^[6].

3. Effect on Sarcopenic Obesity in the Elderly

In the elderly population, oxytocin may have a therapeutic effect on sarcopenic obesity. A double-blind, placebo-controlled randomized controlled trial conducted on 21 older adults (67.5 ± 5.4 years old), obese (30 - 43 kg/m²), sedentary (less than 2 strenuous exercises per week), and with slow gait (less than 1m/s, as a surrogate marker for sarcopenia) showed that intranasal administration of oxytocin (24IU, 4 times a day for 8 weeks) was well tolerated without any serious adverse events. Oxytocin significantly increased the whole-body lean body mass by 2.25kg, showing a significant difference compared with the placebo (P <.01), and had a trend of reducing fat mass. It also significantly reduced plasma low-density lipoprotein cholesterol by -19.3mg/dL (P =.023). However, there were no significant changes in body mass index, appetite scores, blood glucose, plasma high-density lipoprotein, triglycerides, or depressive symptoms ^[7].

4. Effect in Migraine

Recent clinical studies have found that oxytocin has an inhibitory effect on migraines and headaches. Studies have shown that the oxytocin receptor (OTR) is widely expressed in the trigeminovascular system of rats. In the trigeminal ganglion (TG), the expression of OTR was found especially in most A-delta sensory neurons and fibers. OTR is also expressed in the caudal nucleus of the trigeminal nerve, which is the central target of TG afferent fibers. A small number of C fiber sensory neurons in TG express OTR and co-localize with the neuropeptide calcitonin gene-related peptide (CGRP). However, oxytocin has no effect on the potassium ion-induced release of CGRP from isolated TG or TG afferent fibers in the dura mater. In vitro, another peripheral TG target, the cranial artery, contracts in response to oxytocin, and this response can be blocked by the OTR antagonist L368899. Oxytocin immunoreactivity was found in TG satellite glial cells, but oxytocin mRNA was not detected in TG. Therefore, circulating oxytocin is most likely to act on OTRs in TG, thereby affecting pain transmission ^[4].

5. Effects on Gastrointestinal Motility and Secretory Activity

Oxytocin (OT) shows multiple potential effects in regulating gastrointestinal motility and secretory activities. Research shows that OT can improve the gastrointestinal motility disorders caused by the antitumor drug vincristine (VCR), including slowed gastrointestinal transit and reduced response of isolated colon segments to electrical field stimulation. Exogenous OT pretreatment can significantly improve the inhibition of gastrointestinal motility by VCR and the damage to myenteric neurons. In addition, OT can also regulate gastric emptying and gastrointestinal motility. By activating the hypothalamic-vagal oxytocinergic neural circuit, it can prevent stress-induced delayed gastric emptying and motility problems, and increase gastric tone and motility^[8]. In terms of intestinal peristalsis, the OT/OTR signal has a regulatory effect on intestinal peristalsis. The gastrointestinal transit time of OTR knockout (OTRKO) mice is faster than that of wild-type mice, and OT can inhibit the enteric nervous system (ENS)-dependent colonic migrating motor complex generated in vitro^[9]. In terms of gastrointestinal secretory activities, OT regulates intestinal mucosal permeability and cell proliferation, plays a role in the maintenance of the intestinal mucosa, and has a protective effect on colitis^[9]. These research results indicate that the OT/OTR signal plays an important role in various functions of the gastrointestinal tract, including gastrointestinal motility, secretory activit es, and mucosal protection.

In conclusion, Oxytocin promotes the contraction of uterine smooth muscles and the secretion of milk from the mammary glands in the reproductive system, and at the same time regulates social behavior, emotions, and stress responses in the nervous system. In addition, oxytocin also regulates gastrointestinal motility and secretory activities, improves the gastrointestinal motility disorders caused by chemotherapy drugs, promotes gastric emptying, inhibits gastric acid secretion, and has a protective effect on gastric ulcers and colitis. Its multifunctionality makes it have important applications in reproduction, metabolism.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

Scientific Journal Author

Yang L is a researcher associated with Huazhong University of Science & Technology. His research spans several key areas including Neurosciences & Neurology, Pharmacology & Pharmacy, Research & Experimental Medicine, Oncology, and Biochemistry & Molecular Biology. He has made significant contributions to these fields through his academic and research activities. Yang L is listed in the reference of citation [3].

▎Relevant Citations

[1] Li S, Shi Y, Zhu J, et al. Protective effect of oxytocin on vincristine-induced gastrointestinal dysmotility in mice[J]. Frontiers in Pharmacology, 2024,15. DOI: 10.3389/fphar.2024.1270612

[2] Oxytocin[J]. Reactions Weekly, 2019,1735(1):206.DOI:10.1007/s40278-019-56822-x.

[3] Yang L, Chen K, Yin X, et al. The Comprehensive Neural Mechanism of Oxytocin in Analgesia[J]. Current Neuropharmacology, 2022,20(1):147-157.DOI:10.2174/1570159X19666210826142107.

[4] Krause D, Warfvinge K, Grell A, et al. Oxytocin as a regulatory neuropeptide in the trigeminovascular system: localization, expression and function of oxytocin and oxytocin receptors[J]. Faseb Journal, 2020,34.DOI:10.1096/fasebj.2020.34.s1.03383.

[5] Osilla E V, Patel P, Sharma S. Oxytocin[J]. 2025. https://pubmed.ncbi.nlm.nih.gov/29939625/

[6] Rash J A, Campbell T S, Cooper L, et al. Evaluating the efficacy of intranasal oxytocin on pain and function among  individuals who experience chronic pain: a protocol for a multisite,  placebo-controlled, blinded, sequential, within-subjects crossover trial[J]. Bmj Open, 2021,11(9):e55039.DOI:10.1136/bmjopen-2021-055039.

[7] Espinoza S E, Lee J L, Wang C, et al. Intranasal Oxytocin Improves Lean Muscle Mass and Lowers LDL Cholesterol in Older  Adults with Sarcopenic Obesity: A Pilot Randomized Controlled Trial[J]. Journal of the American Medical Directors Association, 2021,22(9):1877-1882.DOI:10.1016/j.jamda.2021.04.015.

[8] Jiang Y, Travagli R A. Hypothalamic-vagal oxytocinergic neurocircuitry modulates gastric emptying and  motility following stress[J]. Journal of Physiology-London, 2020,598(21):4941-4955.DOI:10.1113/JP280023.

[9] Welch M G, Margolis K G, Li Z, et al. Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2014,307(8):G848-G862.DOI:10.1152/ajpgi.00176.2014.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.